Barrier M - Search Results

1

First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.

Verwaerde P, Estrella C, Burlet S, Barrier M, Marotte AA, Clincke G. Verwaerde P, et al. Among authors: barrier m. J Alzheimers Dis. 2024;98(2):715-727. doi: 10.3233/JAD-220883. J Alzheimers Dis. 2024. PMID: 38427472

2

Aroylated phenylenediamine HO53 modulates innate immunity, histone acetylation and metabolism.

Barrier ML, Myszor IT, Sahariah P, Sigurdsson S, Carmena-Bargueño M, Pérez-Sánchez H, Gudmundsson GH. Barrier ML, et al. Mol Immunol. 2023 Mar;155:153-164. doi: 10.1016/j.molimm.2023.02.003. Epub 2023 Feb 20. Mol Immunol. 2023. PMID: 36812763 Free article.

3

AZP2006, a new promising treatment for Alzheimer's and related diseases.

Callizot N, Estrella C, Burlet S, Henriques A, Brantis C, Barrier M, Campanari ML, Verwaerde P. Callizot N, et al. Among authors: barrier m. Sci Rep. 2021 Aug 19;11(1):16806. doi: 10.1038/s41598-021-94708-1. Sci Rep. 2021. PMID: 34413330 Free PMC article.

4

Natural Killer Cells from Allergic Donors Are Defective in Their Response to CCL18 Chemokine.

Amniai L, Ple C, Barrier M, de Nadai P, Marquillies P, Vorng H, Chenivesse C, Tsicopoulos A, Duez C. Amniai L, et al. Among authors: barrier m. Int J Mol Sci. 2021 Apr 9;22(8):3879. doi: 10.3390/ijms22083879. Int J Mol Sci. 2021. PMID: 33918621 Free PMC article.

5

Clinically Meaningful Laboratory Protocols Reduce Hospital Charges Based on Institutional and ACS-NSQIP® Risk Calculators in Hepatopancreatobiliary Surgery.

Pickens RC, King L, Barrier M, Tezber K, Sulzer JK, Cochran A, Lyman WB, McClune G, Iannitti DA, Martinie JB, Baker EH, Ocuin LM, Hanley M, Vrochides D. Pickens RC, et al. Among authors: barrier m. Am Surg. 2019 Aug 1;85(8):883-894. Am Surg. 2019. PMID: 31560308

6

Camk2n1 Is a Negative Regulator of Blood Pressure, Left Ventricular Mass, Insulin Sensitivity, and Promotes Adiposity.

Alfazema N, Barrier M, de Procé SM, Menzies RI, Carter R, Stewart K, Diaz AG, Moyon B, Webster Z, Bellamy COC, Arends MJ, Stimson RH, Morton NM, Aitman TJ, Coan PM. Alfazema N, et al. Among authors: barrier m. Hypertension. 2019 Sep;74(3):687-696. doi: 10.1161/HYPERTENSIONAHA.118.12409. Epub 2019 Jul 22. Hypertension. 2019. PMID: 31327268 Free PMC article.

7

Complement Factor B Is a Determinant of Both Metabolic and Cardiovascular Features of Metabolic Syndrome.

Coan PM, Barrier M, Alfazema N, Carter RN, Marion de Procé S, Dopico XC, Garcia Diaz A, Thomson A, Jackson-Jones LH, Moyon B, Webster Z, Ross D, Moss J, Arends MJ, Morton NM, Aitman TJ. Coan PM, et al. Among authors: barrier m. Hypertension. 2017 Jul 24;70(3):624-33. doi: 10.1161/HYPERTENSIONAHA.117.09242. Online ahead of print. Hypertension. 2017. PMID: 28739975 Free PMC article.

8

Genetic, physiological and comparative genomic studies of hypertension and insulin resistance in the spontaneously hypertensive rat.

Coan PM, Hummel O, Garcia Diaz A, Barrier M, Alfazema N, Norsworthy PJ, Pravenec M, Petretto E, Hübner N, Aitman TJ. Coan PM, et al. Among authors: barrier m. Dis Model Mech. 2017 Mar 1;10(3):297-306. doi: 10.1242/dmm.026716. Epub 2017 Jan 26. Dis Model Mech. 2017. PMID: 28130354 Free PMC article.

9

Involvement of Heme Oxygenase-1 in particulate matter-induced impairment of NO-dependent relaxation in rat intralobar pulmonary arteries.

Barrier M, Bégorre MA, Baudrimont I, Dubois M, Freund-Michel V, Marthan R, Savineau JP, Muller B, Courtois A. Barrier M, et al. Toxicol In Vitro. 2016 Apr;32:205-11. doi: 10.1016/j.tiv.2016.01.005. Epub 2016 Jan 9. Toxicol In Vitro. 2016. PMID: 26780163

10

Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.

Melnyk P, Vingtdeux V, Burlet S, Eddarkaoui S, Grosjean ME, Larchanché PE, Hochart G, Sergheraert C, Estrella C, Barrier M, Poix V, Plancq P, Lannoo C, Hamdane M, Delacourte A, Verwaerde P, Buée L, Sergeant N. Melnyk P, et al. Among authors: barrier m. ACS Chem Neurosci. 2015 Apr 15;6(4):559-69. doi: 10.1021/cn5003013. Epub 2015 Feb 6. ACS Chem Neurosci. 2015. PMID: 25611616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page